A Phase 1 Safety and Pharmacokinetic Study of PC-1005 (MIV-150/Zinc Acetate/Carrageenan Gel) Administered Rectally to HIV-1 Seronegative Adults
Phase of Trial: Phase I
Latest Information Update: 02 May 2019
Price : $35 *
At a glance
- Drugs MIV 150/zinc acetate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 29 Apr 2019 Status changed from active, no longer recruiting to completed.
- 18 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 16 Jul 2018 Status changed from not yet recruiting to recruiting.